Loading...
Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials
BACKGROUND: MGMT methylation status can influence the therapeutic effect and prognosis of glioblastoma (GBM). There are conflicting results from studies evaluating the efficacy of bevacizumab (BV) when it is combined with temozolomide (TMZ) and radiotherapy (RT) in patients diagnosed with GBM with d...
Saved in:
Published in: | Med Sci Monit |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
International Scientific Literature, Inc.
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045921/ https://ncbi.nlm.nih.gov/pubmed/27684457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.899224 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|